17 studies found for:    HLA-DRB1
Show Display Options
RSS Create an RSS feed from your search for:
HLA-DRB1
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome
Condition: Atrophic Glossitis, Burning Mouth Syndrome
Intervention: Dietary Supplement: Supplementation of vitamin B complex, C, B12, folic acid, Iron and Zinic
2 Completed Hepatitis B Vaccine Genetics: A Substudy of ATN 024 and ATN 025
Conditions: HIV Infection;   Hepatitis B
Intervention:
3 Completed DNA Typing of HLA-DR/DQ Alleles in Taiwan Chinese With Rheumatic Heart Disease
Condition: Rheumatic Heart Disease
Intervention: Procedure: venipuncture to withdraw patient's blood
4 Completed Study of Human Leukocyte Antigen (HLA) Polymorphisms in Patients With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Intervention: Biological: Collect of 10 ml of peripheric blood for DNA extraction
5 Recruiting Genetic Study of Antithyroid Drugs Associated Agranulocytosis
Condition: Agranulocytosis
Intervention:
6 Completed
Has Results
Clinical Protocol SeCore, uTYPE and 3500 Dx System
Condition: Human Leukocyte Antigens (HLA)
Intervention:
7 Unknown  Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants
Conditions: Acute Leukemia in Remission;   Myelodysplastic Syndromes;   Leukemia, Myeloid, Chronic-Phase;   Leukemia, Myeloid, Accelerated-Phase
Interventions: Drug: Sirolimus;   Drug: Tacrolimus
8 Recruiting Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies
Conditions: Acute Myelogenous Leukemia;   Myelodysplastic Syndrome;   Acute Lymphocytic Leukemia;   Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma
Interventions: Device: CliniMACS® CD34 Reagent System;   Drug: Fludarabine;   Drug: Melphalan;   Drug: Rabbit ATG;   Procedure: Double Umbilical Cord Blood Transplantation;   Procedure: Haplo-Identical Cord Transplantation
9 Unknown  Randomized Study of ATG for Graft Versus Host Disease (GVHD) Prevention in Paediatric Patients Given an Unrelated Donor Stem Cell Transplantation
Condition: Paediatric Patients Affected by Haematological Malignancies and Eligible to Undergo HSCT From an Unrelated Volunteer
Intervention: Drug: ATG Fresenius
10 Terminated Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies
Condition: Hematologic Malignancies
Interventions: Drug: Fludarabine;   Drug: Busulfan;   Drug: Thymoglobulin;   Radiation: Total Body Irradiation;   Biological: Umbilical Cord Blood
11 Unknown  Therapy Protocol Acute Lymphoblastic Leukemia Stem Cell Transplantation International
Condition: Acute Lymphoblastic Leukemia
Intervention: Procedure: Transplantation with Stem Cells from Umbilical Cord
12 Recruiting Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Interventions: Drug: busulfan;   Drug: melphalan;   Drug: fludarabine;   Biological: anti-thymocyte globulin (ATG);   Procedure: a T cell depleted stem cell transplant
13 Recruiting Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Leukemia
Interventions: Drug: clofarabine;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: decitabine
14 Not yet recruiting Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations
Conditions: Acute Myeloid Leukaemia;   Myelodysplastic Syndrome
Interventions: Drug: Arm A Mylotarg;   Drug: Arm D Cladribine;   Drug: AC220;   Drug: Ganetespib
15 Completed
Has Results
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
Conditions: Melanoma;   Metastases
Interventions: Drug: MDX-010 (anti-CTLA4) monoclonal antibody;   Biological: MDX-1379 (gp100) Melanoma Peptide Vaccine
16 Active, not recruiting
Has Results
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With AML Leukemia
Condition: Leukemia
Interventions: Biological: sargramostim;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: gemtuzumab ozogamicin (GO);   Drug: Daunorubicin;   Procedure: Autologous HCT;   Procedure: Allogeneic HCT
17 Completed Prospective Randomized Study Comparing One or Two High Dose Chemotherapy Regimen Followed by Autologous Stem Cell Transplantation
Condition: Acute Myeloid Leukemia
Interventions: Drug: Zavedos;   Drug: Cerubidine

Indicates status has not been verified in more than two years